Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Sep 28, 2024; 16(9): 389-397
Published online Sep 28, 2024. doi: 10.4329/wjr.v16.i9.389
Cryoablation of osteoid osteomas: Is it a valid treatment option?
Antonios Michailidis, Athanasios Panos, Efthimios Samoladas, Georgios Dimou, Georgia Mingou, Panagiotis Kosmoliaptsis, Maria Arvaniti, Christos Giankoulof, Evangelos Petsatodis
Antonios Michailidis, Georgios Dimou, Georgia Mingou, Panagiotis Kosmoliaptsis, Christos Giankoulof, Evangelos Petsatodis, Department of Interventional Radiology, Georgios Papanikolaou General Hospital of Thessaloniki, Thessaloniki 57010, Greece
Athanasios Panos, Efthimios Samoladas, Department of 1st Orthopaedic Clinic, Georgios Papanikolaou General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki 57010, Greece
Maria Arvaniti, Dental School, EKPA, Athens 15773, Greece
Author contributions: Petsatodis E and Samoladas E designed the research; Michailidis A, Kosmoliaptsis P, Dimou G, and Mingou G performed the research; Petsatodis E and Arvaniti M contributed new reagents or analytic tools; Petsatodis E and Giankoulof C analyzed data; Michailidis A and Panos A wrote the paper.
Institutional review board statement: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of General Hospital of Thessaloniki “G. Papanikolaou” (Protocol Code 77481-12 and 05-04-2024).
Informed consent statement: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Data sharing statement: Consent for publication was obtained for every individual person’s data included in the study.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Evangelos Petsatodis, PhD, Consultant Physician-Scientist, Doctor, Department of Interventional Radiology, Georgios Papanikolaou General Hospital of Thessaloniki, Leoforos Papanikolaou, Exohi, Thessaloniki 57010, Greece. irpapanikolaou@gmail.com
Received: April 17, 2024
Revised: August 20, 2024
Accepted: September 2, 2024
Published online: September 28, 2024
Processing time: 162 Days and 9.4 Hours
Core Tip

Core Tip: This study aims to evaluate percutaneous cryoablation for the treatment of osteoid osteomas. Our results prove that cryoablation is safe and effective as a treatment option for these tumors and has certain advantages over other ablative methods. Cryoablation has the advantage of extraosseous positioning of the cryoprobe, avoiding bone drilling, less procedural and post-procedural pain, making it possible for the procedure to be performed strictly under local anesthesia and the ability to treat larger lesions with a single probe placement.